Artificial Intelligence for Neurosymbolic Clinical Knowledge Reasoning in Complex Healthcare

Abstract

Recent advances in artificial intelligence (AI), particularly the integration of neurosymbolic reasoning, are transforming complex healthcare environments by enabling robust, interpretable, and clinically relevant knowledge synthesis. This review explores the application of neurosymbolic AI for clinical knowledge reasoning, emphasizing its epidemiology, pathophysiological underpinnings, risk factors for implementation, clinical features, diagnostic strategies, management approaches, and recent innovations. The article synthesizes current research, guideline recommendations, and practical implications for healthcare professionals, highlighting both the benefits and challenges of AI adoption in multidisciplinary clinical settings.

Introduction

The exponential growth of clinical data and the increasing complexity of healthcare systems demand advanced decision-support tools that combine the strengths of data-driven machine learning with human-understandable symbolic reasoning. Neurosymbolic AI, which merges neural networks with symbolic logic, offers a paradigm shift in how clinical knowledge is represented, reasoned with, and applied to patient care. This article provides a comprehensive, evidence-based overview of neurosymbolic AI in clinical knowledge reasoning, focusing on its clinical relevance and implications for healthcare professionals.

Epidemiology / Disease Burden

The burden of clinical decision complexity is rising globally, paralleling increases in patient multimorbidity, polypharmacy, and the volume of biomedical literature. Clinical errors, often stemming from knowledge gaps or cognitive overload, significantly impact morbidity and mortality, with studies attributing up to 10% of hospital deaths to preventable errors. The World Health Organization estimates that unsafe care causes approximately 2.6 million deaths annually in low- and middle-income countries. The adoption of AI-powered clinical reasoning tools is projected to reduce diagnostic errors and improve patient outcomes, particularly in high-burden, data-rich specialties such as oncology, cardiology, and critical care.

Pathophysiology

Traditional AI systems in healthcare rely largely on pattern recognition, lacking the ability to incorporate explicit domain knowledge, causal relationships, or guideline-based logic. Neurosymbolic AI addresses these limitations by integrating neural networks—capable of learning from unstructured data—with symbolic reasoning engines that represent medical concepts, ontologies, and rules. This hybrid architecture enables systems to perform deductive reasoning, causal inference, and guideline adherence checks, mimicking expert clinical thinking. Mechanistically, neurosymbolic models map patient data to symbolic representations (such as SNOMED CT or ICD codes) and apply logic-based reasoning for differential diagnosis, risk stratification, and treatment recommendations.

Risk Factors

The implementation of neurosymbolic AI in healthcare faces several risk factors. Data heterogeneity, incomplete electronic health records, and bias in training datasets can undermine model reliability and generalizability. Clinician resistance, stemming from concerns over transparency, accountability, and workflow integration, poses additional barriers. Regulatory uncertainties and the risk of automation bias—where clinicians over-rely on AI outputs—necessitate robust validation and monitoring. Ethical considerations, including patient consent, data privacy, and explainability, are crucial for responsible deployment in clinical settings.

Clinical Features

Neurosymbolic AI-driven clinical decision support systems exhibit several defining features: interpretability, context-awareness, and the ability to incorporate structured medical knowledge alongside unstructured patient data. These systems can generate case-specific explanations, align with clinical guidelines, and dynamically update recommendations as new evidence emerges. For example, in complex cases involving multimorbidity, neurosymbolic models can reconcile conflicting guidelines and suggest personalized care pathways, supporting multidisciplinary teams in real time.

Diagnosis

Diagnostic reasoning supported by neurosymbolic AI leverages both machine-learned associations and explicit clinical logic. Systems can synthesize patient symptoms, laboratory results, imaging data, and historical context to generate ranked differential diagnoses, highlighting rationale and evidence for each suggestion. Recent studies demonstrate improved diagnostic accuracy and reduced cognitive load when clinicians use neurosymbolic tools, particularly in rare diseases or atypical presentations. These systems are increasingly being integrated into electronic medical records (EMRs), providing context-sensitive, guideline-concordant diagnostic support at the point of care.

Treatment & Management

Neurosymbolic AI enhances treatment planning by encoding clinical guidelines, pharmacological knowledge, and patient-specific factors (such as comorbidities, allergies, and genetics) into decision algorithms. These systems facilitate shared decision-making by presenting treatment options, risks, and anticipated outcomes in an interpretable format. For chronic disease management, neurosymbolic approaches enable longitudinal reasoning, monitoring disease trajectories, and dynamically adjusting care plans. Clinical trials have shown improved adherence to evidence-based protocols and reduced adverse events when neurosymbolic AI supports therapeutic decisions.

Recent Advances / Emerging Therapies

Recent advances in neurosymbolic AI include the development of self-explaining neural-symbolic architectures, integration with biomedical knowledge graphs, and real-time inferencing capabilities. Notable research includes the use of transformer-based models augmented with ontological reasoning for rare disease diagnosis and the application of symbolic logic to reconcile conflicting clinical guidelines in multimorbidity. Emerging therapies include AI-driven precision medicine platforms that synthesize genomics, imaging, and clinical data to identify optimal interventions. Pilot studies in oncology, critical care, and infectious diseases have demonstrated the feasibility and clinical utility of these approaches, with ongoing trials evaluating impact on patient outcomes.

Guideline Recommendations

Professional societies and regulatory agencies emphasize the need for transparency, validation, and clinician oversight in the deployment of neurosymbolic AI systems. Guidelines recommend multidisciplinary collaboration in model development, rigorous external validation, and ongoing performance monitoring. The importance of explainable AI is highlighted, ensuring that recommendations are interpretable and actionable by healthcare professionals. Integration with existing clinical workflows, ethical compliance, and patient engagement are also key recommendations for successful adoption.

Conclusion

Neurosymbolic AI represents a transformative advance in clinical knowledge reasoning, offering the potential to enhance diagnostic accuracy, guideline adherence, and individualized patient care in complex healthcare settings. While challenges remain in data quality, implementation, and regulation, emerging evidence supports the clinical value and safety of these systems. Ongoing research, clinician engagement, and adherence to best-practice guidelines will be essential to realize the full potential of neurosymbolic AI in improving patient outcomes and healthcare system efficiency.